Patent details
EP2420240
Title:
Azithromycin for the treatment of nodular acne
Basic Information
- Publication number:
- EP2420240
- PCT Application Number:
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP111889606
- PCT Publication Number:
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- Azithromycin for the treatment of nodular acne
- French Title of Invention:
- L'azithromycine pour le traitement de l'acné nodulaire
- German Title of Invention:
- Azithromycin zur Behandlung von knotiger Akne
- SPC Number:
-
Dates
- Filing date:
- 24/09/2007
- Grant date:
- 11/05/2016
- EP Publication Date:
- 11/05/2016
- PCT Publication Date:
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 22/02/2012
- EP B1 Publication Date:
- 11/05/2016
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 24/09/2016
- Expiration date:
- 24/09/2027
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 24/09/2007
-
-
- Name:
- Dow Pharmaceutical Sciences Inc.
- Address:
- 1330a Redwood Way, Petaluma CA 94954-6542, United States (US)
Inventor
1
- Name:
- Chaudhuri Bhaskar
- Address:
- United States (US)
2
- Name:
- Osborne David Wade
- Address:
- United States (US)
3
- Name:
- Calvarese Barry
- Address:
- United States (US)
4
- Name:
- Dow Gordon Jay
- Address:
- United States (US)
Priority
1
- Priority Number:
- 849065 P
- Priority Date:
- 03/10/2006
- Priority Country:
- United States (US)
2
- Priority Number:
- 635127
- Priority Date:
- 06/12/2006
- Priority Country:
- United States (US)
Classification
- Main IPC Class:
-
A61K 31/70;
Annual Fees
- Annual Fee Due Date:
-
- Annual Fee Number:
-
- Expected Payer:
-
- Last Annual Fee Payment Date:
-
- Last Annual Fee Paid Number:
-
- Payer:
-
Filing date |
Document type |
Number of pages |